Marina Siakantaris
National and Kapodistrian University of Athens
H-index: 33
Europe-Greece
Top articles of Marina Siakantaris
Monitoring Humoral Response Following BNT162b2 mRNA Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplantation Patients: A Single-Center Prospective Study along …
2024/4/16
Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients
Cancers
2024/1/5
TREATMENT STRATEGIES AND PROGNOSTIC FACTORS FOR THE OUTCOME OF PATIENTS WITH HODGKIN LYMPHOMA EXPERIENCING VERY LATE RELAPSES AFTER CHEMOTHERAPY±RADIOTHERAPY
Hematological Oncology
2023/6
A Case Report of Chronic Myelogenous Leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic Leukemia Phenotype: Awareness of a Rare Entity
2023/12/22
PET for Response Assessment to R‐da‐EPOCH in Primary Mediastinal Large B‐cell lymphoma: Who Is Worthy to be Irradiated?
HemaSphere
2023/11
Prolonged 3-year spontaneous remission of diffuse large B-cell lymphoma upon withdrawal of infliximab and late relapse in a patient with psoriasis: a case report and review of …
2023/8/24
P1121: POSITRON EMISSION TOMOGRAPHY FOR FINAL RESPONSE ASSESSMENT TO RITUXIMAB-DOSE ADJUSTED EPOCH IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: WHO IS WORTHY TO BE IRRADIATED?
HemaSphere
2023/8/1
Marina Siakantaris
H-Index: 16
Eleftheria Hatzimichael
H-Index: 25
Evangelos Terpos
H-Index: 61
Helen Papadaki
H-Index: 18
Maria Angelopoulou
H-Index: 22
P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP
HemaSphere
2023/8/1
Marina Siakantaris
H-Index: 16
Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version
Annals of Hematology
2023/8
EVALUATION OF GONADAL FUNCTION IN YOUNG MEN AND WOMEN DIAGNOSED WITH HODGKIN LYMPHOMA
Hematological Oncology
2023/6
EVALUATION OF FERTILITY IN WOMEN TREATED WITH THE R‐DA‐EPOCH REGIMEN FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA (PMBCL)
Hematological Oncology
2023/6
REAL‐LIFE EXPERIENCE WITH RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐da‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A MULTINATIONAL ANALYSIS OF 274 PATIENTS
Hematological Oncology
2023/6
The Prognostic Significance of Serum Beta-2 Microglobulin (sβ2m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent …
Blood
2022/11/15
P114: Very late relapses in patients with Hodgkin Lymphoma occuring≥ 5 years after initial treament with chemotherapy±radiotherapy: Treatment strategies and prognostic factors …
HemaSphere
2022/10/1
Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors
Blood Cancer Journal
2022/7/5
P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES
HemaSphere
2022/6/1
P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): THE …
HemaSphere
2022/6/1
P1085: EVALUATION OF GONADAL FUNCTION IN YOUNG WOMEN DIAGNOSED WITH HODGKIN AND NON-HODGKIN LYMPHOMA
HemaSphere
2022/6/1
Marina Siakantaris
H-Index: 16
Sophia Kalantaridou
H-Index: 22
Real-life experience with rituximab-CHOP Every 21 or 14 days in primary mediastinal large B-cell lymphoma
in vivo
2022/5/1
Genetic polymorphisms and risk of MALT lymphoma in Greek population
Current Research in Translational Medicine
2022/5/1
